AAAAAA
Results:
1-7
|
Results: 7
Authors:
METTANG T
THOMAS S
MACHLEIDT C
FISCHER FP
KUHLMANN U
RETTENMEIER AW
Citation: T. Mettang et al., UREMIC PRURITUS AND EXPOSURE TO DI(2-ETHYLHEXYL)PHTHALATE (DEHP) IN HEMODIALYSIS-PATIENTS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1213-1213
Authors:
METTANG T
SCHENK U
THOMAS S
MACHLEIDT C
KIEFER T
FISCHER FP
KUHLMANN U
Citation: T. Mettang et al., LOW-DOSE INTRADERMAL VERSUS INTRAMUSCULAR HEPATITIS-B VACCINATION IN PATIENTS WITH END-STAGE RENAL-FAILURE - A PRELIMINARY-STUDY, Nephron, 72(2), 1996, pp. 192-196
Authors:
MACHLEIDT C
Citation: C. Machleidt, ABUSE OF DIURETICS, Deutsche Medizinische Wochenschrift, 120(51-52), 1995, pp. 1802-1802
Authors:
MORIKE K
MAGADUM S
METTANG T
GRIESE EU
MACHLEIDT C
KUHLMANN U
Citation: K. Morike et al., PROPAFENONE IN A USUAL DOSE PRODUCES SEVERE SIDE-EFFECTS - THE IMPACTOF GENETICALLY-DETERMINED METABOLIC STATUS ON DRUG-THERAPY, Journal of internal medicine, 238(5), 1995, pp. 469-472
Authors:
METTANG T
THOMAS S
KIEFER T
SCHENK U
FISCHER FP
MACHLEIDT C
KUHLMANN U
Citation: T. Mettang et al., INTRADERMAL (ID) VERSUS INTRAMUSCULAR HEPATITIS-B VACCINATION (HEP-B-VAC) IN PATIENTS WITH END-STAGE RENAL-FAILURE (ESRD), Journal of the American Society of Nephrology, 5(3), 1994, pp. 338-338
Authors:
METTANG T
WEBER J
SCHENK U
MACHLEIDT C
KUHLMANN U
Citation: T. Mettang et al., INTRADERMAL HEPATITIS-B VACCINATION IN NONRESPONSIVE HEMODIALYSIS-PATIENTS, Renal failure, 15(5), 1993, pp. 655-656
Authors:
METTANG T
FRITZ P
WEBER J
MACHLEIDT C
HUBEL E
KIEFER T
KUHLMANN U
Citation: T. Mettang et al., EPIDERMAL LANGERHANS CELLS IN UREMIC PATIENTS ON HEMODIALYSIS OR CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS, Nephron, 65(2), 1993, pp. 278-283
Risultati:
1-7
|